Dr. Shyamal H. Mehta, MD, PhD

Dr. Mehta practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Mehta's NPI, 1104039882, was assigned on May 8, 2007. Dr. Mehta graduated from Medical College of Georgia School of Medicine in 1998. Dr. Mehta holds Arizona license 47568.

Dr. Mehta's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Mehta's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Mehta is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dr. Mehta's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Mehta's licenses on file in 2 states: Arizona and Georgia.

CMS data shows 27,187 Medicare services from Dr. Mehta across 14 procedure codes in 2024, for 461 Medicare patients. Medicare paid $210,667 for them. Every service was in an office.

CMS counts 461 Medicare patients who saw Dr. Mehta in 2024. The largest group is 75 to 84, with 208 patients. 72% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 73, with 47% women.

In 2024, Dr. Mehta wrote 1,502 Medicare Part D claims for 263 patients. 89% of them were for generic drugs. CMS names the drug for 1,411 of them, across 26 drugs with 11 or more claims each, at $333,406 in total drug cost. In 2023, CMS named 1,166 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Mehta for performance year 2024, reported as part of a group. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 81 papers to Dr. Mehta, published from 2012 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Parkinson Disease, alpha-Synuclein and Alzheimer Disease. Dr. Mehta has published most often in Mov Disord. Dr. Mehta's most frequent co-authors are Charles H. Adler, MD, Erika D. Driver-Dunckley, MD and Holly A. Shill, MD.

Dmand AI links Dr. Mehta to 2 clinical trials. Conditions studied include Disorders of Excessive Somnolence, Tardive Dyskinesia and Dyskinesia, Drug-Induced. Open Payments lists research payments to Dr. Mehta that name 1 trial.

CMS Open Payments shows 175 general payments to Dr. Mehta from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Abbott Laboratories paid the most, $16,932. It also lists 4 research payments totaling $20,269 in 2020, naming 1 clinical trial.

Dr. Mehta graduated from Medical College of Georgia School of Medicine in 1998.